Charles River Laboratories | CRL - 利息收入

股票价格

158.00

每天变化

4.40 2.86%

每月一次

-4.85%

每年

-5.38%

Q1 预测

148.99

金融业

USD

USD 7.14B

现金及等价物

USD 213.77M

USD 722.27M

USD 1.45B

USD 1.12B

USD 2.63B

USD 75.82M

USD 258.06M

18.6K

EPS每股收益

USD 2.39

股本和储备

USD 3.16B

USD 271.96M

债务利息支出

USD 23.78M

USD 1.1

USD 2.14B

USD 8.06B

USD -276.56M

USD 918.41M

USD 75.82M

普通股股本

USD 49.22M

43.58

USD 170.03M

USD 994.2M

销售和管理费用

USD 196.14M

USD 299.1M

贸易债权人

USD 148.8M

应收帐款人

USD 1.43B

	利息收入	更改		日
Agilent	USD 17M		1000K	2025-09
Align Technology	USD 3.25M		390K	2025-09
Bio-Rad Laboratories	USD 13.7M		1000K	2025-09
Bruker	USD 4.4M		1.5M	2025-09
Charles River Laboratories	USD 1.1		1.1M	2025-09
Concord Medical Services Hldg	CNY 5.8M		659K	2023-06
Danaher	USD 1.27		8M	2025-09
Dentsply International	USD 4M		1000K	2025-03
Galapagos	EUR 12.56M		4.66M	2025-03
Hologic	USD 0.79		18.9M	2025-12
Illumina	USD 0.98		10M	2025-09
Incyte	USD 30.75M		3.97M	2025-12
Intrexon	USD 319K		602K	2024-06
IQVIA Holdings	USD 13M		3M	2025-09
Merck	EUR 27M		10M	2025-09
Pfizer	USD 0.62		156M	2025-09
Quest Diagnostics	USD 3M		1000K	2025-09
Revvity	USD 0.4		8.34M	2025-09
Thermo Fisher Scientific	USD 4.27		297M	2025-09
United Therapeutics	USD 46.4M		4.9M	2025-09
Veradigm	USD 1.7M		1.6M	2022-09
Waters	USD 2.5		4.51M	2025-09
West Pharmaceutical Services	USD 4.7M		1.1M	2025-09